Androgen and prostatic stroma
- PMID: 12646998
Androgen and prostatic stroma
Abstract
Aim: To investigate the effect of androgen on the proliferation, differentiation and regression of canine prostatic stromal cells in vivo and human stromal cells in vitro.
Methods: Twenty-two dogs, including 15 normal prostate dogs and 7 prostatic hyperplasia dogs, had their serum concentration of testosterone and estrodiol determined by radioimmunoassay before and after castration. The expression of androgen receptor (AR) and estrogen receptor (ER) in the prostate were analysed by immunohistochemistry and semi-quantitative RT-PCR before and after castration. Light microscopy, transmission electron microscopy and TUNEL assay were carried out successively before and after castration to evaluate the prostatic histomorphology. In vitro serum-free cell cultures from human prostatic stroma were established and exposed to dihydrotestosterone (DHT). The proliferation of the cell culture was detected by MTT assay. The expression of TGFbgr, bFGF, AR, and smooth muscle cell (SMC) specific proteins (myosin and/or smoothelin) were detected using immunohistochemistry and RT-PCR. The differentiation from fibroblasts to smooth muscle cells was deduced by measuring the expression of SMC specific proteins.
Results: Before castration, the serum concentrations of testosterone and estrodiol were not statistically different between normal and hyperplasia groups. Following castration, the serum concentration of testosterone decreased rapidly in 2 days, and the concentration of estrodiol had no significant change compared with the pre-castration data. In the prostate, AR was presented in both the epithelial and stromal cells and the AR mRNA level was higher in hyperplasia than in normal prostate tissues (P<0.05). While ER predominantly existed in the prostate stromal cells and the ER mRNA had no difference between the hyperplasia and the normal group. Within the early phase of castration (<d7), the expression of AR was increased rapidly. Then it gradually dropped to a lower level than that of the pre-castration by the end of d90. The expression of ER remained unchanged in the whole course. The prostatic stromal cells, including SMCs and fibroblasts, diminished and underwent serial pathological changes of atrophy and apoptosis after castration. The atrophic cells were filled with huge intracellular lipofuscin. The expression of SMC myosin declined after castration, coincident with the increase in TGFbgr mRNA level and decline in bFGF mRNA level. In vitro, DHT caused a weak increase in the proliferation and expression of SMC-specific proteins (P<0.05). However, DHT and bFGF together stimulated the proliferation of stromal cells significantly more than either agent alone (P<0.01). The combination of DHT and TGFbgr greatly enhanced the expression of SMC-specific proteins (P<0.01) more strongly than either alone (P<0.01).
Conclusion: The whole prostate gland is an androgen-sensitive organ with both the epithelium and stroma under the control of androgen. Androgen may direct the proliferation, differentiation and regression of stromal cells by regulating the expression of TGFbgr, bFGF, AR and smooth muscle cell specific proteins.
Similar articles
-
Proliferation and differentiation of prostatic stromal cells.BJU Int. 2001 Mar;87(4):386-93. doi: 10.1046/j.1464-410x.2001.00103.x. BJU Int. 2001. PMID: 11251536
-
Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1335-43. doi: 10.1152/ajpendo.00017.2009. Epub 2009 Apr 14. Am J Physiol Endocrinol Metab. 2009. PMID: 19366880
-
Stromal cells of the human prostate: initial isolation and characterization.Prostate. 1996 Feb;28(2):89-97. doi: 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I. Prostate. 1996. PMID: 8604397
-
Clinical and experimental studies of benign prostatic hyperplasia.Urol Clin North Am. 1990 Aug;17(3):461-75. Urol Clin North Am. 1990. PMID: 1695775 Review.
-
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.Lab Invest. 1984 Mar;50(3):294-302. Lab Invest. 1984. PMID: 6199584 Review.
Cited by
-
Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells.Mol Biol Rep. 2008 Jun;35(2):107-17. doi: 10.1007/s11033-007-9059-5. Epub 2007 Mar 13. Mol Biol Rep. 2008. PMID: 17431821
-
Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications.Front Endocrinol (Lausanne). 2019 Apr 11;10:225. doi: 10.3389/fendo.2019.00225. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31110491 Free PMC article. Review.
-
Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.Am J Pathol. 2015 Feb;185(2):293-301. doi: 10.1016/j.ajpath.2014.10.012. Epub 2014 Nov 26. Am J Pathol. 2015. PMID: 25432062 Free PMC article. Review.
-
Prostatic artery occlusion: initial findings on pathophysiological response in a canine prostate model.Transl Androl Urol. 2022 Dec;11(12):1655-1666. doi: 10.21037/tau-22-423. Transl Androl Urol. 2022. PMID: 36632152 Free PMC article.
-
Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs.BMC Urol. 2006 Apr 18;6:12. doi: 10.1186/1471-2490-6-12. BMC Urol. 2006. PMID: 16620393 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials